Suppr超能文献

经鼻腔给予间充质干细胞为修复新生儿缺血性脑损伤创造了一个有利于再生的微环境。

Intranasally administered mesenchymal stem cells promote a regenerative niche for repair of neonatal ischemic brain injury.

机构信息

Lab. of Neuroimmunology and Developmental Origins of Disease, University Medical Center Utrecht, Utrecht, The Netherlands.

Biomedical MR Imaging and Spectroscopy Group, Image Sciences Institute, University Medical Center Utrecht, The Netherlands.

出版信息

Exp Neurol. 2014 Nov;261:53-64. doi: 10.1016/j.expneurol.2014.06.009. Epub 2014 Jun 16.

Abstract

Previous work from our group has shown that intranasal MSC-treatment decreases lesion volume and improves motor and cognitive behavior after hypoxic-ischemic (HI) brain damage in neonatal mice. Our aim was to determine the kinetics of MSC migration after intranasal administration, and the early effects of MSCs on neurogenic processes and gliosis at the lesion site. HI brain injury was induced in 9-day-old mice and MSCs were administered intranasally at 10days post-HI. The kinetics of MSC migration were investigated by immunofluorescence and MRI analysis. BDNF and NGF gene expression was determined by qPCR analysis following MSC co-culture with HI brain extract. Nestin, Doublecortin, NeuN, GFAP, Iba-1 and M1/M2 phenotypic expression was assessed over time. MRI and immunohistochemistry analyses showed that MSCs reach the lesion site already within 2h after intranasal administration. At 12h after administration the number of MSCs at the lesion site peaks and decreases significantly at 72h. The number of DCX(+) cells increased 1 to 3days after MSC administration in the SVZ. At the lesion, GFAP(+)/nestin(+) and DCX(+) expression increased 3 to 5days after MSC-treatment. The number of NeuN(+) cells increased within 5days, leading to a dramatic regeneration of the somatosensory cortex and hippocampus at 18days after intranasal MSC administration. Interestingly, MSCs expressed significantly more BDNF gene when exposed to HI brain extract in vitro. Furthermore, MSC-treatment resulted in the resolution of the glial scar surrounding the lesion, represented by a decrease in reactive astrocytes and microglia and polarization of microglia towards the M2 phenotype. In view of the current lack of therapeutic strategies, we propose that intranasal MSC administration is a powerful therapeutic option through its functional repair of the lesion represented by regeneration of the cortical and hippocampal structure and decrease of gliosis.

摘要

先前我们的研究小组已经证明,经鼻给予间充质干细胞(MSC)治疗可减少新生小鼠缺氧缺血性(HI)脑损伤后的病灶体积,并改善运动和认知行为。我们的目的是确定经鼻给予 MSC 后 MSC 迁移的动力学,以及 MSC 对损伤部位神经发生过程和神经胶质增生的早期影响。在 9 日龄的小鼠中诱导 HI 脑损伤,并在 HI 后 10 天经鼻给予 MSC。通过免疫荧光和 MRI 分析来研究 MSC 迁移的动力学。通过 MSC 与 HI 脑提取物共培养,用 qPCR 分析 BDNF 和 NGF 基因表达。随着时间的推移,评估巢蛋白、双皮质素、NeuN、GFAP、Iba-1 和 M1/M2 表型的表达。MRI 和免疫组织化学分析显示,MSC 在经鼻给药后 2 小时内即可到达损伤部位。给药后 12 小时,损伤部位的 MSC 数量达到峰值,72 小时后显著减少。在 MSC 给药后 1 至 3 天,SVZ 中的 DCX(+)细胞数量增加。在损伤部位,GFAP(+)/巢蛋白(+)和 DCX(+)表达在 MSC 治疗后 3 至 5 天增加。NeuN(+)细胞数量在 5 天内增加,导致经鼻 MSC 给药后 18 天体感皮层和海马体的剧烈再生。有趣的是,MSC 在体外暴露于 HI 脑提取物时表达更多的 BDNF 基因。此外,MSC 治疗导致损伤周围的神经胶质瘢痕消退,表现为反应性星形胶质细胞和小胶质细胞减少,小胶质细胞向 M2 表型极化。鉴于目前缺乏治疗策略,我们提出经鼻给予 MSC 是一种有效的治疗选择,可通过皮质和海马结构的再生和神经胶质增生的减少来实现损伤的功能修复。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验